Unknown

Dataset Information

0

Defining normal adrenal function testing in the intensive care unit setting: a canine study.


ABSTRACT: OBJECTIVE:To determine whether intensive care medicine therapies and testing influence hypothalamic-pituitary-adrenal test results. It is routine in intensive care medicine to measure hypothalamic-pituitary-adrenal function, commonly utilizing the adrenocorticotropic hormone stimulation test to diagnose absolute or relative adrenal insufficiency. DESIGN:Prospective, 96-hr animal study. SETTING:Research laboratory. SUBJECTS:Twenty-four healthy canines. INTERVENTIONS:Animals were randomized into two groups--awake and unrestrained or treated with intensive care medicine therapies, including sedation, intubation, and mechanical ventilation. Animals were further randomized to receive dexamethasone (or placebo) or undergo either a total of four or seven adrenocorticotropic hormone stimulation tests over 96 hrs. MEASUREMENTS AND MAIN RESULTS:Sedation, intubation, and mechanical ventilation transiently increased both basal and postadrenocorticotropic hormone total and free cortisol concentrations >2-fold as compared with baseline for the first 24 hrs (p < or = .05 for both). Performance of seven stimulation tests increased both basal and postadrenocorticotropic hormone total and free cortisol concentrations from baseline by >1.5-fold for the duration of the 96-hr study (p < or = .05). Neither sedation, intubation, and mechanical ventilation nor the performance of more stimulation tests affected delta cortisol measurements (total or free cortisol, p = NS). In contrast, dexamethasone suppressed basal total cortisol concentrations by >2-fold (p < or = .005) at all time points and transiently increased delta total cortisol by approximately 35% during the first 24 hrs of the study (p < or = .05). CONCLUSIONS:Total and free cortisol measurements--whether pre- or post- adrenocorticotropic hormone or as a calculated delta--were altered by intensive care therapies or frequent adrenocorticotropic hormone stimulation testing with one exception. Delta free cortisol was the only hypothalamic-pituitary-adrenal measurement unaffected by sedation, intubation, and mechanical ventilation, completion of more adrenocorticotropic hormone stimulation tests, or dexamethasone therapy. These findings support the need to determine normal ranges for hypothalamic-pituitary-adrenal testing in subjects receiving intensive care medicine before establishing laboratory criteria for the diagnosis of relative adrenal insufficiency.

SUBMITTER: Sweeney DA 

PROVIDER: S-EPMC3635109 | biostudies-literature | 2010 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Defining normal adrenal function testing in the intensive care unit setting: a canine study.

Sweeney Daniel A DA   Natanson Charles C   Banks Steven M SM   Solomon Steven B SB   Behrend Ellen N EN  

Critical care medicine 20100201 2


<h4>Objective</h4>To determine whether intensive care medicine therapies and testing influence hypothalamic-pituitary-adrenal test results. It is routine in intensive care medicine to measure hypothalamic-pituitary-adrenal function, commonly utilizing the adrenocorticotropic hormone stimulation test to diagnose absolute or relative adrenal insufficiency.<h4>Design</h4>Prospective, 96-hr animal study.<h4>Setting</h4>Research laboratory.<h4>Subjects</h4>Twenty-four healthy canines.<h4>Intervention  ...[more]

Similar Datasets

| PRJNA561526 | ENA
2012-05-11 | E-GEOD-37944 | biostudies-arrayexpress
2012-05-12 | GSE37944 | GEO
| PRJNA562118 | ENA
| S-EPMC5094333 | biostudies-literature
| PRJNA562155 | ENA
| S-EPMC9208537 | biostudies-literature
| S-EPMC5747308 | biostudies-literature
2021-11-17 | GSE176498 | GEO
| S-EPMC6259085 | biostudies-other